Table 1. Characteristics of eligible CPGs.
| No | Year | Country/region | Language | Developer | Grading system | IF | Funding source |
|---|---|---|---|---|---|---|---|
| 1 (12) | 2020 | China | Chinese | CRHA, CMA (CSS. CPSA) | GRADE | None | Unreported |
| 2 (13) | 2020 | Europe | English | ESTRO, ACROP | Unreported | 4.856 | Society |
| 3 (14) | 2020 | China | Chinese | NCRC-RT, CIMB (CSIP), CIM (CFC) | Unreported | None | Unreported |
| 4 (15) | 2019 | Japan | English | JPS | GRADE | 2.92 | Society |
| 5 (16) | 2020 | Global | English | IAP, APA, JPS, EPC | GRADE | 3.629 | Unreported |
| 6 (17) | 2020 | France | English | INCA | GRADE | 4.848 | Government |
| 7 (18) | 2019 | Australia | English | AGITG | Unreported | 2.948 | Government |
| 8 (19) | 2020 | Spain | English | SEOM, AEC, SEOR, SEEN, SEPD, SERAM, SEAP | GRADE | 2.737 | Society |
| 9 (20) | 2020 | USA | English | ASCO | GRADE | 32.956 | Society |
| 10 (21) | 2020 | Europe | English | ESMO | Unreported | 5.329 | Society |
| 11 (22) | 2019 | USA | English | ASCO | GRADE | 32.956 | Society |
| 12 (23) | 2020 | Global | English | CAPS consortium | Unreported | 19.819 | Government |
| 13 (24) | 2019 | Poland | English | Working group of PCC | Self-defined | None | Unreported |
| 14 (25) | 2019 | USA | English | ASTRO | ASTRO | 2.948 | Unreported |
| 15 (26) | 2019 | USA | English | USPSTF | USPSTF | 45.54 | Government |
| 16 (27) | 2019 | USA | English | ASCO | GRADE | 32.956 | Society |
| 17 (28) | 2018 | France | English | Several French medical and surgical societies | GRADE | 3.57 | Unreported |
| 18 (29) | 2018 | Global | English | Working group | GRADE | 3.629 | Unreported |
| 19 (30) | 2018 | China | Chinese | PCCCAA | Unreported | None | Unreported |
| 20 (31) | 2018 | China | English | NHC of the PRC | Unreported | 4.135 | Unreported |
| 21 (32) | 2018 | UK | English | NICE | Unreported | Website | Unreported |
| 22 (33) | 2020 | USA | English | NCCN | Self-defined | Website | Unreported |
CPGs, clinical practice guidelines; AEC, the Spanish Association of Surgeons; AGITG, The Australasian Gastrointestinal Trials Group; APA, the American Pancreatic Association; ASCO, The American Society of Clinical Oncology; ASTRO, American Society for Radiation Oncology; CAPS, international Cancer of the Pancreas Screening; CIM (CFC), Committee of Interventional Medicine (Cancer Foundation of China); CIMB (CSIP), Committee of Interventional Medicine and Bioengineering (Chinese Society of Interventional Physicians); CPSA (CSS.CMA), Chinese Pancreatic Surgery Association (Chinese Society of Surgery. Chinese Medical Association); CRHA, Chinese Research Hospital Association; EPC, European Pancreatic Club; ESMO, European Society for Medical Oncology; IAP, the International Association of Pancreatology; INCA, The French National Cancer Institute; JPS, Japan Pancreas Society; NCRC-RT, National Clinical Research Center for Radiology and Therapy; NHC of the PRC, The National Health Commission of the People’s Republic of China; PCC, the Polish Pancreatic Club; PCCCAA, Pancreatic cancer committee of Chinese anti-cancer association; SEOM, the Spanish Society of Medical Oncology; SEOR, the Spanish Society of Radiation Oncology; SEEN, the Spanish Society of Endocrinology; SEPD, the Spanish Society of Digestive Pathology; SERAM, the Spanish Society of Medical Radiology; SEAP, the Spanish Society of Pathology; USPSTF, US Preventive Services Task Force.